These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4591413)

  • 21. Recurrent glomerulonephritis due to anti-glomerular basement membrane-antibodies in two successive allografts.
    Beleil OM; Coburn JW; Shinaberger JH; Glassock RJ
    Clin Nephrol; 1973; 1(6):377-80. PubMed ID: 4594999
    [No Abstract]   [Full Text] [Related]  

  • 22. Rabbit anti rat lymphocyte serum: immunosuppression mediated by a pure IgM fraction.
    Jakobsen A; Flatmark A; Harboe M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Oct; 81(5):635-40. PubMed ID: 4209178
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of administration of steroids in treatment of renal-allograft rejection.
    Touraine JL; Traeger J
    Lancet; 1978 Mar; 1(8064):607. PubMed ID: 76143
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model.
    Reichenspurner H; Human PA; Rose AG; Reichart B; Cooper DK
    Transplant Proc; 1990 Jun; 22(3):1086-7. PubMed ID: 2349666
    [No Abstract]   [Full Text] [Related]  

  • 26. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal allograft rupture and its management.
    Yadav RV; Sinha R; Datta BN
    Int Surg; 1985; 70(4):361-3. PubMed ID: 3914474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM; Mendes NF; Ramos OL; Sabbaga E
    Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
    Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal transplantation in pediatric patients.
    Lawson RK; Talwalkar YB; Musgrave JE; Campbell RA; Hodges CV
    J Urol; 1975 Feb; 113(2):225-9. PubMed ID: 1089815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late rupture of the renal graft: not always graft rejection.
    Fernández-Juárez G; Pascual J; Burgos FJ; Mampaso F; Cano T; Liaño F; García-González R; Ortuño J
    Nephrol Dial Transplant; 1998 Feb; 13(2):496-8. PubMed ID: 9580227
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy].
    Bullinger W; Hammer C; Land W; Welter H
    Chir Forum Exp Klin Forsch; 1979; ():319-24. PubMed ID: 378592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal allograft rupture: a report of three cases and review of the literature.
    Thukral R; Mir AR; Jacobson MP
    Am J Nephrol; 1982; 2(1):15-27. PubMed ID: 6758580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-discharge, post-transplant kidney biopsy does not predict rejection.
    Matas AJ; Sibley R; Mauer SM; Kim Y; Sutherland DE; Simmons RL; Najarian JS
    J Surg Res; 1982 Mar; 32(3):269-74. PubMed ID: 7040806
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of peripheral blood leukocyte activity following canine renal allotransplantation.
    Pauly JL; Varkarakis MJ; Germain MJ; Murphy GP
    J Med; 1974; 5(5):221-8. PubMed ID: 4606248
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cyclophosphamide therapy in kidney transplants].
    Stummvoll HK; Egert H; Böhmig HJ; Pinggera WF
    Wien Z Inn Med; 1973; 54(4):145-9. PubMed ID: 4587180
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
    Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):20-2. PubMed ID: 2964112
    [No Abstract]   [Full Text] [Related]  

  • 38. [Spontaneous rupture of the allotransplanted kidney].
    Poisson J; Le Guillou M; Scetbon V; Leroux-Robert C; Küss R
    J Urol Nephrol (Paris); 1973; 79(7):575-86. PubMed ID: 4592403
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical renal transplantation.
    Kountz SL
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract]   [Full Text] [Related]  

  • 40. Cadaveric kidney transplantation in a patient with donor-specific antileukocyte cytotoxic antibodies. Report of a case.
    Patel R; Wilson RE; Birtch AG; Merrill JP; Murray JE; Busch G
    Transplantation; 1971 Jul; 12(1):88-91. PubMed ID: 4932701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.